Search by Drug Name or NDC

NDC 69848-0018-16 Guaifenesin 1200 mg/1 Details

Guaifenesin 1200 mg/1

Guaifenesin is a ORAL TABLET, EXTENDED RELEASE in the HUMAN OTC DRUG category. It is labeled and distributed by GRANULES USA, INC.. The primary component is GUAIFENESIN.

MedlinePlus Drug Summary

Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.

Related Packages: 69848-0018-16
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Guaifenesin

Product Information

NDC	69848-0018
Product ID	69848-018_0dfd5775-138b-c205-e063-6394a90a2022
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Guaifenesin
Proprietary Name Suffix	n/a
Non-Proprietary Name	Guaifenesin
Product Type	HUMAN OTC DRUG
Dosage Form	TABLET, EXTENDED RELEASE
Route	ORAL
Active Ingredient Strength	1200
Active Ingredient Units	mg/1
Substance Name	GUAIFENESIN
Labeler Name	GRANULES USA, INC.
Pharmaceutical Class	Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA213420
Listing Certified Through	2025-12-31

Package

NDC 69848-0018-16 (69848001816)

Pricing Information	N/A
NDC Package Code	69848-018-16
Billing NDC	69848001816
Package	14 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (69848-018-16)
Marketing Start Date	2021-02-21
NDC Exclude Flag	N